Atypical mycobacteria keratitis after laser in situ keratomileusis unresponsive to fourth-generation fluoroquinolone therapy

Journal of Cataract and Refractive Surgery

Volumn 33, Issue 7, 2007, Pages 1318-1321

  de la Cruz, Jose ^a   Behlau, Irmgard ^a   Pineda, Roberto ^a  

^a Infectious Disease Unit   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CIPROFLOXACIN; CLARITHROMYCIN; GATIFLOXACIN; MOXIFLOXACIN; PREDNISOLONE ACETATE;

ADULT; ARTICLE; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; CASE REPORT; CATARACT; CONJUNCTIVAL HYPEREMIA; CORNEA EDEMA; DIFFUSE LAMELLAR KERATITIS; DISEASE COURSE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; HUMAN; INTRAOCULAR FOREIGN BODY; KERATOMILEUSIS; MALE; MYCOBACTERIUM CHELONEI; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TISSUE CULTURE; TREATMENT RESPONSE; VISUAL ACUITY;

ADULT; ANTI-INFECTIVE AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; EYE INFECTIONS, BACTERIAL; FLUOROQUINOLONES; HUMANS; KERATITIS; KERATOMILEUSIS, LASER IN SITU; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYOPIA; SURGICAL FLAPS; SURGICAL WOUND INFECTION;

EID: 34250785231     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2007.03.035     Document Type: Article

References (23)

1. Cruz J.C. Mycobacterium fortuitum un nuovo bacillo acido-resistente patogenico para o homem. Acta Med Rio de Janeiro 1 (1938) 297-301
2. Turner L., and Stinson I. Mycobacterium fortuitum as a cause of corneal ulcer. Am J Ophthalmol 60 (1965) 329-331
3. ®). Surv Ophthalmol 50 suppl (2005) S7-S15
4. Mather R., Karenchak L., Romanowski E.G., and Kowalski R.P. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 133 (2002) 463-466
5. Hamam R.N., Noureddin B., Salti H., et al. Recalcitrant post-LASIK Mycobacterium chelonae keratitis eradicated after the use of fourth-generation fluoroquinolones. Ophthalmology 113 (2006) 950-954
6. Brown-Elliott B.A., Wallace Jr. R.J., Crist C.J., et al. Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria. Antimicrob Agents Chemother 46 (2002) 3283-3285
7. John T., and Velotta E. Nontuberculous (atypical) mycobacterial keratitis after LASIK; current status and clinical implications. Cornea 24 (2005) 245-255
8. O'Brien T.P., and Matoba A.Y. Nontuberculous mycobacterial diseases. In: Pepose J.S., Holland G.N., and Wilhelmus K.R. (Eds). Ocular Infection & Immunity (1996), Mosby, St. Louis, MO 1033-1041
9. Daines B.S., Vroman D.T., Sandoval H., et al. Rapid diagnosis and treatment of mycobacterial keratitis after laser in situ keratomileusis. J Cataract Refract Surg 29 (2003) 1014-1018
10. Bullington Jr. R.H., Lanier J.D., and Font R.L. Nontuberculous mycobacteria keratitis; report of two cases and review of the literature. Arch Ophthalmol 110 (1992) 519-524
11. Dalovisio J.R., and Pankey G.A. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin. J Infect Dis 137 (1978) 318-321
12. Gross R.H., Holland G.N., Elias S.J., and Tuz R. Corneal pharmacokinetics of topical clarithromycin. Invest Ophthalmol Vis Sci 36 (1995) 965-968
13. Ford J.G., Huang A.J.W., Pflugfelder S.C., et al. Nontuberculous mycobacterial keratitis in south Florida. Ophthalmology 105 (1998) 1652-1658
14. Chung M.S., Goldstein M.H., Driebe Jr. W.T., and Schwartz B. Mycobacteria chelonae keratitis after laser in situ keratomileusis successfully treated with medical therapy and flap removal. Am. J Ophthalmol 129 (2000) 382-384
15. Solomon A., Karp C.L., Miller D., et al. Mycobacteria interface keratitis after laser in situ keratomileusis. Ophthalmology 108 (2001) 2201-2208
16. Fulcher S.F.A., Fader R.C., Rosa Jr. R.H., and Holmes G.P. Delayed onset mycobacterial keratitis after LASIK. Cornea 21 (2002) 546-554
17. Hu F.-R., and Luh K.-T. Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis. Ophthalmology 105 (1998) 269-272
18. Khardori N., Nguyen H., Rosenbaum B., et al. In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents. Antimicrob Agents Chemother 38 (1994) 134-137
19. Leibowitz H.M. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol 112 suppl (1991) 34S-47S
20. Hwang D.G., and Biswell R. Ciprofloxacin therapy of Mycobacteria chelonae keratitis. [letter]. Am J Ophthalmol 115 (1993) 114-115
21. Abshire R., Cockrum P., Crider J., and Schlech B. Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis treatment. Clin Ther 26 (2004) 191-196
22. Höfling-Lima A.L., de Freitas D., Mello Sampaio L., et al. In vitro activity of fluoroquinolones against Mycobacterium abscessus and Mycobacterium chelonae causing infectious keratitis after LASIK in Brazil. Cornea 24 (2005) 730-734
23. Freitas D., Alvarenga L., Sampaio J., et al. An outbreak of Mycobacterium chelonae infection keratitis after LASIK. Ophthalmology 110 (2003) 276-285